Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 3, Issue 2, 2022

Progress in Serological Markers in Lung Cancer TCM Syndrome Types and Efficacy Evaluation of Chinese Medicine

Download as PDF

DOI: 10.23977/medsc.2022.030205 | Downloads: 8 | Views: 650

Author(s)

Rf Yang 1, Fx Feng 2, Yx Ma 2

Affiliation(s)

1 Academy of Medical Technology of Shaanxi University of Chinese Medicine, Xianyang Shaanxi 712000, China
2 Department of Laboratory Medicine, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xianyang Shaanxi 712000, China

Corresponding Author

Yx Ma

ABSTRACT

Lung cancer is the most common lung malignancy, and is the highest incidence rate and mortality rate in cancer. The detection of serum tumor markers or combined detection has a certain reference value for the diagnosis and condition monitoring of lung cancer, and the expression of tumor markers has a certain relationship with TCM syndrome differentiation. Therefore, this paper mainly reviews the etiology and pathogenesis of lung cancer, TCM syndrome types, the correlation between serum markers and TCM syndrome types of lung cancer, and whether serum tumor markers can be used as an evaluation index in the treatment of lung cancer with integrated traditional Chinese and Western medicine.

KEYWORDS

Lung Cancer, TCM Syndrome Type, Tumor Marker

CITE THIS PAPER

Rf Yang, Fx Feng, Yx Ma, Progress in Serological Markers in Lung Cancer TCM Syndrome Types and Efficacy Evaluation of Chinese Medicine. MEDS Clinical Medicine (2022) Vol. 3: 22-29. DOI: http://dx.doi.org/10.23977/medsc.2022.030205.

REFERENCES

[1] Tian Yantao, Kang Wenzhe. New progress of global cancer incidence research [J]. Chinese Medicine, 2021, 16(10): 1446-1447.
[2] Lu T, Yang X, Huang Y, Zhao M, Li M, Ma K, Yin J, Zhan C, Wang Q. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag Res. 2019Jan 21; 11: 943-953. doi: 10.2147/CMAR.S187317. a
[3] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
[4] Ge Junbo, Xu Yongjian. Internal Medicine [M]. 9th Ed. Beijing: People's Medical Publishing House, 2018.
[5] Shao Yun, Guan Jiangfeng. Psychological needs and nursing strategies of lung cancer patients undergoing chemotherapy for the first time [J]. Health Care Medicine Research and Practice, 2018, 15(02): 70-72.
[6] Liu Xia,Wang Yan,Yang Fumeng.Detection of serum β 2-Mg, CEA, CA125, NSE and CyFRA21-1 in early diagnosis of lung cancer [J]. Jilin Medical Science, 2021, 42(01): 8-11.
[7] Cai Yun, Chen Yuanbin, YE Fang, WU Lei, LI Liu, Lin Lin. TCM master Zhou Zhongying's experience in differentiation and treatment of lung cancer from the theory of cancer toxicity [J]. Chinese Journal of Traditional Chinese Medicine, 2020, 35(06): 2879-2882.
[8] Li Hegen. Professor Liu Jiaxiang's experience in the treatment of lung cancer by strengthening the normal method [J]. Sichuan Traditional Chinese Medicine, 2005(07): 5-6.
[9] Xue Xin-li. Lin Hong-sheng clinical experience in the treatment of non-small cell lung cancer by invigorating qi and nourishing Yin [J]. Global Chinese Medicine, 2015, 8(08): 983-984.
[10] Guan Tianyu, Gu Yifang. Gu Mingsan's experience in the treatment of advanced lung cancer[J]. Journal of Internal Medicine of Practical Traditional Chinese Medicine, 2011, 25(05): 17+19.
[11] Hu Yan, Tan Kaiji, Chen Zhijian, Cao Yang. Introduction of Professor Chen Ruishen's experience in the treatment of lung cancer [J]. New Traditional Chinese medicine, 2008, 40(12): 8-9.
[12] Cui Huijuan, Zhang Peiyu. Zhang Daizhao's experience in the treatment of lung cancer [J]. Journal of China-Japan Friendship Hospital, 2011, 25(01): 57-58.
[13] Ma Ke, Ma Ling, Shi Zhiming. Study on standardization of TCM syndromes of primary bronchial lung cancer [J]. Liaoning Journal of Traditional Chinese Medicine, 2007(04): 421-422.
[14] Xiao B, Long S Q, Deng H. Distribution characteristics of TCM syndrome types in 207 cases of advanced non-small cell lung cancer [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2013, 15(03): 188-190.
[15] Zhang Ming-ping, Wang Jian-jun, LI Zhi-hong. Clinical observation of TCM syndrome type in advanced non-small cell lung cancer [J]. World Journal of Integrated Traditional Chinese and Western Medicine, 2012, 7(08) :706-708.
[16] Han D, Li W, Fang R. Clinical investigation of TCM syndrome types in 861 cases of primary lung cancer [J]. Shanxi traditional Chinese medicine, 2016, 37(12): 1589-1591.
[17] Xu Yinji, Wang Xinqiu, Chao Enxiang. Chao Enxiang's experience in the treatment of lung cancer [J]. New Traditional Chinese Medicine, 2016, 48(08): 228-229.
[18] Deng Yunzong, Sun Hongxin, Zheng Xijun. Zhou Daihan's experience in the treatment of lung cancer [J]. Journal of Traditional Chinese Medicine 2017, 32(03): 318-321.
[19] Deng Hong, He Wenfeng, Li Liuning, Wu Wanyin, Long Shunqin. Liu Weisheng clinical experience in treatment of lung cancer [J]. Shi Zhen Chinese medicine, 2011, 22(09): 2312-2314.
[20] Jiang Jianhong,Xu Li. Professor Xu Li's experience in the treatment of lung cancer with "three segments and six discriminations" model [J]. Chinese Medicine Guide, 2016, 22(18): 31-34.
[21] Zhang Shuhong, LIU Jian, Rao Zhiguo. Study on the correlation between TCM syndrome types and clinical objective indicators of non-small cell lung cancer [J]. Chinese Journal of Traditional Chinese Medicine, 2020, 35(02): 295-298.
[22] Wang Lei, Ning Xiaoxiao, Li Hegen, Wang Qihua, XU Weijie, Zhou Lei, Xu Ling. Analysis of the relationship between TCM syndromes and histological types, clinical stages and tumor markers in patients with lung cancer [J]. Laboratory medicine, 2013, 28(05): 387-390.
[23] Dai Sui, Zhao Jing, Li Huiqiang. Study on the relationship between TCM syndromes and tumor markers in non-small cell lung cancer [J]. Shaanxi Traditional Chinese Medicine, 2014, 35(03): 312-313.
[24] Yan Xuesheng, Li Hanmin, Peng Yaqin. Study on the correlation between tumor markers and TCM syndrome differentiation of lung cancer [J]. Hubei Journal of Traditional Chinese Medicine, 2007(09): 11-12.
[25] Lv Dan, Wang Baishan, Li Yali, Zhang Cheng, Jin Di. Study on the correlation between tumor markers cyFRA21-1, CEA, CA12-5, NSE and TCM syndrome differentiation in patients with lung cancer[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2019, 21(06): 165-167.
[26] Fu Yanli, Tu Hongbin, Dong Zhiyi, Dong Changsheng, XU Ling. Study on the correlation between TCM syndrome type and TNM stage and tumor antigen in primary lung cancer [J]. World Science and Technology – Modernization of Traditional Chinese medicine, 2015, 17(06): 1210-1214.
[27] Shan Kuizhong, Jiang Ziyu, Huang Hui. Effects of integrated traditional Chinese and Western medicine on tumor markers and cellular immune function in patients with advanced non-small cell lung cancer [J]. World Traditional Chinese Medicine, 2018, 13(10): 2472-2475.
[28] Cui Yanfei, Huang Chuying. Clinical efficacy of Qingfexiaoji Prescription combined with chemotherapy in elderly patients with advanced non-small cell lung cancer and its effect on tumor markers, inflammatory factors and immune function [J]. Chinese Journal of Traditional Chinese Medicine Information, 2018, 25(12): 19-23.
[29] Chen Yanfeng, Zhou Deqi. Efficacy of self-designed Yiqi Yangyin Xiaoai Decoction combined with docetaxel in the treatment of non-small cell lung cancer and its effect on serumtumor markers [J]. Journal of Modern Integrated Chinese and Western Medicine, 2018, 27(09): 942-945+1026.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4608
Visits: 200382

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.